139 related articles for article (PubMed ID: 1711148)
41. Potent and specific inhibition of human immunodeficiency virus type 1 replication by 4-(2,6-dichlorophenyl)-1,2,5-thiadiazol-3-Y1 N,N-dialkylcarbamate derivatives.
Ijichi K; Fujiwara M; Hanasaki Y; Watanabe H; Katsuura K; Takayama H; Shirakawa S; Sakai S; Shigeta S; Konno K
Antimicrob Agents Chemother; 1995 Oct; 39(10):2337-40. PubMed ID: 8619592
[TBL] [Abstract][Full Text] [Related]
42. Comparative QSAR based on neural networks for the anti-HIV activity of HEPT derivatives.
Douali L; Villemin D; Cherqaoui D
Curr Pharm Des; 2003; 9(22):1817-26. PubMed ID: 12871199
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and anti-HIV-1 activity of new fluoro-HEPT analogues: an investigation on fluoro versus hydroxy substituents.
Loksha YM; Pedersen EB; Loddo R; La Colla P
Arch Pharm (Weinheim); 2011 Jun; 344(6):366-71. PubMed ID: 21456073
[TBL] [Abstract][Full Text] [Related]
44. Antiviral activities of nucleotide heterodimers against human immunodeficiency virus type 1 in vitro.
Ijichi K; Fujiwara M; Mori K; Morozumi M; Machida H; Shigeta S; Konno K; Yokota T; Baba M
Antiviral Res; 1996 Jun; 31(1-2):115-20. PubMed ID: 8793015
[TBL] [Abstract][Full Text] [Related]
45. Resistance of human immunodeficiency virus type 1 to acyclic 6-phenylselenenyl- and 6-phenylthiopyrimidines.
Nguyen MH; Schinazi RF; Shi C; Goudgaon NM; McKenna PM; Mellors JW
Antimicrob Agents Chemother; 1994 Oct; 38(10):2409-14. PubMed ID: 7840579
[TBL] [Abstract][Full Text] [Related]
46. Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.
Pauwels R; Andries K; Debyser Z; Van Daele P; Schols D; Stoffels P; De Vreese K; Woestenborghs R; Vandamme AM; Janssen CG
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1711-5. PubMed ID: 7680476
[TBL] [Abstract][Full Text] [Related]
47. New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs.
Pauwels R; Andries K; Debyser Z; Kukla MJ; Schols D; Breslin HJ; Woestenborghs R; Desmyter J; Janssen MA; De Clercq E
Antimicrob Agents Chemother; 1994 Dec; 38(12):2863-70. PubMed ID: 7535037
[TBL] [Abstract][Full Text] [Related]
48. Structure-Based design of [(2-Hydroxyethoxy)methyl]-6-(phenylthio)-thymine derivatives as nonnucleoside HIV-1 reverse transcriptase Inhibitors: From HEPTs to Sulfinyl-substituted HEPTs.
Hao Q; Wang S; Huang W; Zhang Y; Pannecouque C; De Clercq E; Chen F
Bioorg Chem; 2022 Sep; 126():105880. PubMed ID: 35649315
[TBL] [Abstract][Full Text] [Related]
49. Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.
Romero DL; Busso M; Tan CK; Reusser F; Palmer JR; Poppe SM; Aristoff PA; Downey KM; So AG; Resnick L
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8806-10. PubMed ID: 1717988
[TBL] [Abstract][Full Text] [Related]
50. Action of uracil analogs on human immunodeficiency virus type 1 and its reverse transcriptase.
Piras G; Dutschman GE; Im GJ; Pan BC; Chu SH; Cheng YC
Antimicrob Agents Chemother; 1995 Feb; 39(2):539-41. PubMed ID: 7537030
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptase.
Velázquez S; Alvarez R; San-Félix A; Jimeno ML; De Clercq E; Balzarini J; Camarasa MJ
J Med Chem; 1995 May; 38(10):1641-9. PubMed ID: 7538589
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV.
Maruyama T; Kozai S; Yamasaki T; Witvrouw M; Pannecouque C; Balzarini J; Snoeck R; Andrei G; De Clercq E
Antivir Chem Chemother; 2003 Sep; 14(5):271-9. PubMed ID: 14694990
[TBL] [Abstract][Full Text] [Related]
53. A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
Miyasaka T; Tanaka H; Baba M; Hayakawa H; Walker RT; Balzarini J; De Clercq E
J Med Chem; 1989 Dec; 32(12):2507-9. PubMed ID: 2479745
[No Abstract] [Full Text] [Related]
54. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
[TBL] [Abstract][Full Text] [Related]
55. Nonnucleoside HIV-1 reverse-transcriptase inhibitors, part 5. Synthesis and anti-HIV-1 activity of novel 6-naphthylthio HEPT analogues.
Sun GF; Chen XX; Chen FE; Wang YP; De Clercq E; Balzarini J; Pannecouque C
Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):886-92. PubMed ID: 16079514
[TBL] [Abstract][Full Text] [Related]
56. HIV inhibitors targeted at the reverse transcriptase.
De Clercq E
AIDS Res Hum Retroviruses; 1992 Feb; 8(2):119-34. PubMed ID: 1371690
[TBL] [Abstract][Full Text] [Related]
57. New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase.
Bellarosa D; Antonelli G; Bambacioni F; Giannotti D; Viti G; Nannicini R; Giachetti A; Dianzani F; Witvrouw M; Pauwels R; Desmyter J; De Clercq E
Antiviral Res; 1996 May; 30(2-3):109-24. PubMed ID: 8783803
[TBL] [Abstract][Full Text] [Related]
58. A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis.
Afantitis A; Melagraki G; Sarimveis H; Koutentis PA; Markopoulos J; Igglessi-Markopoulou O
Mol Divers; 2006 Aug; 10(3):405-14. PubMed ID: 16896545
[TBL] [Abstract][Full Text] [Related]
59. Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
Tanaka H; Baba M; Saito S; Miyasaka T; Takashima H; Sekiya K; Ubasawa M; Nitta I; Walker RT; Nakashima H
J Med Chem; 1991 Apr; 34(4):1508-11. PubMed ID: 2016729
[No Abstract] [Full Text] [Related]
60. Specific HIV-1 reverse transcriptase inhibitors.
Debyser Z; Pauwels R; Andries K; De Clercq E
J Enzyme Inhib; 1992; 6(1):47-53. PubMed ID: 1285302
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
